These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 16960831
1. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system. Gao H, Wang YN, Fan YG, Ma JB. J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831 [Abstract] [Full Text] [Related]
2. Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system. Gao H, Wang YN, Fan YG, Ma JB. J Control Release; 2005 Sep 20; 107(1):158-73. PubMed ID: 16095747 [Abstract] [Full Text] [Related]
3. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. McCarron PA, Marouf WM, Donnelly RF, Scott C. J Biomed Mater Res A; 2008 Dec 15; 87(4):873-84. PubMed ID: 18228271 [Abstract] [Full Text] [Related]
4. Conjugates of poly(DL-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(beta-cyclodextrin)s and their nanoparticles as protein delivery systems. Gao H, Yang YW, Fan YG, Ma JB. J Control Release; 2006 May 30; 112(3):301-11. PubMed ID: 16616967 [Abstract] [Full Text] [Related]
5. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH, Taluja A, Knutson K, Han Bae Y. J Control Release; 2005 Dec 05; 109(1-3):86-100. PubMed ID: 16266769 [Abstract] [Full Text] [Related]
6. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization. Porjazoska A, Goracinova K, Mladenovska K, Glavas M, Simonovska M, Janjević EI, Cvetkovska M. Acta Pharm; 2004 Sep 05; 54(3):215-29. PubMed ID: 15610618 [Abstract] [Full Text] [Related]
7. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel. Liu SQ, Tong YW, Yang YY. Mol Biosyst; 2005 Jul 05; 1(2):158-65. PubMed ID: 16880979 [Abstract] [Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. Nanomedicine; 2007 Dec 05; 3(4):246-57. PubMed ID: 18068091 [Abstract] [Full Text] [Related]
10. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM. Int J Pharm; 2010 May 05; 390(1):70-5. PubMed ID: 19836438 [Abstract] [Full Text] [Related]
11. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein. Cai C, Bakowsky U, Rytting E, Schaper AK, Kissel T. Eur J Pharm Biopharm; 2008 May 05; 69(1):31-42. PubMed ID: 18023160 [Abstract] [Full Text] [Related]
12. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Gvili K, Benny O, Danino D, Machluf M. Biopolymers; 2008 May 05; 85(5-6):379-91. PubMed ID: 17266128 [Abstract] [Full Text] [Related]
13. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW, Wang SS, Tsai WJ. Biomaterials; 2008 Jan 05; 29(2):228-37. PubMed ID: 17953984 [Abstract] [Full Text] [Related]
14. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Cheng FY, Wang SP, Su CH, Tsai TL, Wu PC, Shieh DB, Chen JH, Hsieh PC, Yeh CS. Biomaterials; 2008 May 05; 29(13):2104-12. PubMed ID: 18276001 [Abstract] [Full Text] [Related]
15. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles. Kim BS, Kim CS, Lee KM. Arch Pharm Res; 2008 Aug 05; 31(8):1050-4. PubMed ID: 18787796 [Abstract] [Full Text] [Related]
16. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Derakhshandeh K, Erfan M, Dadashzadeh S. Eur J Pharm Biopharm; 2007 Apr 05; 66(1):34-41. PubMed ID: 17070678 [Abstract] [Full Text] [Related]
17. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, Schäller S, Bakowsky U, Kissel T. J Control Release; 2007 May 14; 119(1):41-51. PubMed ID: 17346845 [Abstract] [Full Text] [Related]
18. Interactions of some modified mono- and bis-beta-cyclodextrins with bovine serum albumin. Gao H, Wang YN, Fan YG, Ma JB. Bioorg Med Chem; 2006 Jan 01; 14(1):131-7. PubMed ID: 16183293 [Abstract] [Full Text] [Related]
19. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Cirpanli Y, Bilensoy E, Lale Doğan A, Caliş S. Eur J Pharm Biopharm; 2009 Sep 01; 73(1):82-9. PubMed ID: 19442723 [Abstract] [Full Text] [Related]
20. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Cırpanlı Y, Allard E, Passirani C, Bilensoy E, Lemaire L, Calış S, Benoit JP. Int J Pharm; 2011 Jan 17; 403(1-2):201-6. PubMed ID: 20951783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]